ZA202100375B - Therapy of high-risk human papillomavirus infections - Google Patents

Therapy of high-risk human papillomavirus infections

Info

Publication number
ZA202100375B
ZA202100375B ZA2021/00375A ZA202100375A ZA202100375B ZA 202100375 B ZA202100375 B ZA 202100375B ZA 2021/00375 A ZA2021/00375 A ZA 2021/00375A ZA 202100375 A ZA202100375 A ZA 202100375A ZA 202100375 B ZA202100375 B ZA 202100375B
Authority
ZA
South Africa
Prior art keywords
acid
human papillomavirus
therapy
composition
risk human
Prior art date
Application number
ZA2021/00375A
Other languages
English (en)
Inventor
Norbert Fuchs
Original Assignee
Selo Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selo Medical Gmbh filed Critical Selo Medical Gmbh
Publication of ZA202100375B publication Critical patent/ZA202100375B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA2021/00375A 2018-08-28 2021-01-19 Therapy of high-risk human papillomavirus infections ZA202100375B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18191289.0A EP3616693A1 (en) 2018-08-28 2018-08-28 Therapy of high-risk human papillomavirus infections
PCT/EP2019/072926 WO2020043762A1 (en) 2018-08-28 2019-08-28 Therapy of high-risk human papillomavirus infections

Publications (1)

Publication Number Publication Date
ZA202100375B true ZA202100375B (en) 2024-08-28

Family

ID=63442535

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2021/00375A ZA202100375B (en) 2018-08-28 2021-01-19 Therapy of high-risk human papillomavirus infections

Country Status (25)

Country Link
US (2) US20210299163A1 (https=)
EP (2) EP3616693A1 (https=)
JP (1) JP7420791B2 (https=)
CN (1) CN112584828A (https=)
AR (1) AR116027A1 (https=)
AU (1) AU2019332079B2 (https=)
BR (1) BR112021003360A2 (https=)
CA (1) CA3107691C (https=)
CL (1) CL2021000197A1 (https=)
EA (1) EA202190441A1 (https=)
ES (1) ES2958808T3 (https=)
GE (2) GEAP202215586A (https=)
HR (1) HRP20231470T1 (https=)
HU (1) HUE064691T2 (https=)
IL (1) IL281080B2 (https=)
MA (1) MA53482B1 (https=)
MD (1) MD3843715T2 (https=)
MX (1) MX2021002310A (https=)
PL (1) PL3843715T3 (https=)
RS (1) RS64916B1 (https=)
SM (1) SMT202300340T1 (https=)
TW (1) TWI827652B (https=)
UA (1) UA127632C2 (https=)
WO (1) WO2020043762A1 (https=)
ZA (1) ZA202100375B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3875083A1 (en) * 2020-03-03 2021-09-08 Selo Medical GmbH Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2245301C2 (ru) 2000-05-10 2005-01-27 Окофарм Форшунгс-Унд Энтвиклюнгс-Гмбх Способ уменьшения площади поверхности диоксида кремния
AT412758B (de) 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
AT412448B (de) 2001-02-13 2005-03-25 Vis Vitalis Lizenz & Handels Verwendung von selenhältigen präparaten
AT412703B (de) * 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
AT511159A1 (de) * 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen

Also Published As

Publication number Publication date
CN112584828A (zh) 2021-03-30
CA3107691A1 (en) 2020-03-05
JP7420791B2 (ja) 2024-01-23
JP2021536454A (ja) 2021-12-27
GEP20227432B (en) 2022-10-25
EA202190441A1 (ru) 2021-06-15
MD3843715T2 (ro) 2023-12-31
AU2019332079B2 (en) 2024-08-29
CA3107691C (en) 2024-10-29
EP3616693A1 (en) 2020-03-04
RS64916B1 (sr) 2023-12-29
IL281080A (en) 2021-04-29
EP3843715A1 (en) 2021-07-07
WO2020043762A1 (en) 2020-03-05
IL281080B1 (en) 2024-08-01
HUE064691T2 (hu) 2024-04-28
US20250281524A1 (en) 2025-09-11
TWI827652B (zh) 2024-01-01
AR116027A1 (es) 2021-03-25
BR112021003360A2 (pt) 2021-05-11
EP3843715B1 (en) 2023-09-13
PL3843715T3 (pl) 2024-02-19
MA53482B1 (fr) 2023-11-30
UA127632C2 (uk) 2023-11-08
MA53482A (fr) 2021-07-07
ES2958808T3 (es) 2024-02-15
MX2021002310A (es) 2021-04-28
IL281080B2 (en) 2024-12-01
US20210299163A1 (en) 2021-09-30
HRP20231470T1 (hr) 2024-03-01
SMT202300340T1 (it) 2023-11-13
EP3843715C0 (en) 2023-09-13
TW202023534A (zh) 2020-07-01
CL2021000197A1 (es) 2021-09-20
AU2019332079A1 (en) 2021-02-11
GEAP202215586A (en) 2022-06-27

Similar Documents

Publication Publication Date Title
JP2017057230A5 (https=)
M Tebit et al. Mucosal transmission of human immunodeficiency virus
WO2007121894A3 (en) Hpv-18-based papillomavirus vaccine
WO2007121895A3 (en) Hpv-16-based papillomavirus vaccine
WO2002090382A3 (fr) Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
JP2016513703A5 (https=)
JP2006512413A5 (https=)
CA2510457A1 (en) Hpv-16 and -18 l1 vlp vaccine
ZA202100375B (en) Therapy of high-risk human papillomavirus infections
WO2019222768A3 (en) Aqueous hypohalous acid preparations for the inactivation of resistant infectious agents
CN101181636B (zh) 一种防治人乳头瘤病毒感染的复方疫苗组合物、复方疫苗阴道喷雾剂及其用途
MX2018013475A (es) Acido carboxilico para tratar/prevenir congestion nasal.
Lee et al. A case of isolated bowenoid papulosis of the nipple
JP2021536454A5 (https=)
MX2019013371A (es) Biomarcadores clinicos e inmunologicos para la regresion de la displasia de cuello uterino de grado elevado y eliminacion de infeccion por hpv16 y hpv18 luego de la inmunoterapia.
Tauber et al. Unresectable perineal cuniculatum carcinoma: partial remission using systemic isotretinoin and interferon-α2a therapy
MX2022016148A (es) Formulaciones.
EA202190589A1 (ru) Способ комбинированной терапии дисплазии шейки матки, ассоциированной с вирусами папилломы человека
Pestrikova et al. Assessment of viral load in patients with HPV-associated cervicitis during the course of complex treatment
Afshar et al. Clinical and Public Health Considerations for HPV Infection in Men: A Narrative Review
AU2015335652B2 (en) Cancer and skin lesion treatment
Gil-Prieto et al. The burden of hospitalizations for anus and penis neoplasm in Spain (1997–2008)
IL317684A (en) Vehicle for the treatment of human papillomavirus (HPV) infection
IL296146A (en) Preparations containing compounds containing selenite for use in the treatment of cervical cell abnormalities
Prilepskaya et al. Current approaches in the diagnosis, treatment and prevention of HPV-associated cervical diseases: practical recommendations. A review